Scoop has an Ethical Paywall
Scoop InfoPages
This InfoPage in unregistered, if this is your news page register PHARMAC for InfoPages here.
PHARMAC - Latest News [Page 17]
Further antipsychotic treatment gets funding tick
Monday, 1 December 2008, 12:53 pm | PHARMAC
People with schizophrenic disorders have a new funded treatment available from today. More >>
Drug company scaremongering, says Pharmac
Tuesday, 25 November 2008, 4:16 pm | PHARMAC
People can be confident a generic version of a widely-used gastrointestinal drug will work just as well as the medicine it is replacing, says PHARMAC. More >>
2008 decisions highlight funding tensions
Thursday, 16 October 2008, 10:22 am | PHARMAC
The past year has emphasised the difficult trade-offs that PHARMAC faces in allocating pharmaceutical spending, says CEO Matthew Brougham. More >>
New guidance for antipsychotic use in elderly
Tuesday, 7 October 2008, 10:11 am | PHARMAC
PHARMAC and the College of Psychiatrists have today jointly launched new guidance on the use of antipsychotic medicines in the elderly. More >>
Two newly funded treatments for prostate disease
Wednesday, 1 October 2008, 11:29 am | PHARMAC
PHARMAC is to begin funding treatments for two types of prostate disease in men - prostate cancer and benign prostatic hyperplasia (BPH). More >>
Consultation on alternative thyroid treatment
Tuesday, 30 September 2008, 2:21 pm | PHARMAC
PHARMAC has begun consultation on a proposal to subsidise a further brand of the thyroid treatment levothyroxine. Consultation is a further step towards introducing an alternative to the Eltroxin brand that is currently funded. More >>
Increased condoms range a win-win
Thursday, 21 August 2008, 12:51 am | PHARMAC
Funding a wider range of condoms saves taxpayers money, increases choice and promotes better sexual health practices, PHARMAC says. Responding to comments on its decision to fund a wider range of condoms including textured, coloured and flavoured condoms, ... More >>
Once-a-day treatment for ADHD funded
Tuesday, 19 August 2008, 2:55 pm | PHARMAC
A once-a-day treatment for people with ADHD, (Attention Deficit Hyperactivity Disorder) is being funded from 1 September. More >>
Once-a-day treatment for ADHD funded
Tuesday, 19 August 2008, 2:26 pm | PHARMAC
A once-a-day treatment for people with ADHD, (Attention Deficit Hyperactivity Disorder) is being funded from 1 September. More >>
New treatment option for persistent migraines
Monday, 18 August 2008, 9:34 am | PHARMAC
People having trouble controlling persistent migraines will have a new treatment option from 1 September. More >>
PHARMAC funds new treatment for skin cancers
Wednesday, 13 August 2008, 2:18 pm | PHARMAC
A new treatment is being funded for people with a generally non-malignant form of skin cancer. More >>
PHARMAC reaffirms confidence in 9 week treatment
Thursday, 7 August 2008, 3:07 pm | PHARMAC
After extensive investigation, PHARMAC has declined an application from the pharmaceutical company Roche to fund 12 month treatments with the breast cancer drug Herceptin, but will continue to fully fund the 9 week treatment. More >>
Medicine funding up $17 million
Friday, 18 July 2008, 10:42 am | PHARMAC
The Minister of Health has approved an increased community pharmaceuticals budget for the 2008/09 financial year. The budget of $653 million represents a $17 million increase on 2007/08. More >>
Calls for comment on advisory committee guidelines
Tuesday, 20 May 2008, 10:13 am | PHARMAC
PHARMAC is reviewing the guidelines under which its main clinical advisory committee operates. The Pharmacology and Therapeutics Advisory Committee (PTAC) is a statutory committee that provides advice to the Government drug-funding agency. More >>
Prescribing decline a healthy trend
Tuesday, 13 May 2008, 10:39 am | PHARMAC
A continuing decline in prescription figures for the most commonly used antibiotics is a healthy sign, says PHARMAC’s Medical Director Dr Peter Moodie. PHARMAC has today launched the 11th annual Wise Use of Antibiotics campaign, aimed at encouraging ... More >>
Herceptin consultation underway
Monday, 5 May 2008, 1:04 pm | PHARMAC
PHARMAC has today begun consulting on a proposal to decline funding for 12 months’ treatment for HER2 positive early breast cancer with Herceptin. More >>
Matthew Brougham appointed PHARMAC’s CEO
Wednesday, 16 April 2008, 11:33 am | PHARMAC
The appointment confirms Matthew Brougham in the position he has held in an interim capacity since July 2006. More >>
New PHARMAC website designed to meet users’ needs
Monday, 14 April 2008, 9:34 am | PHARMAC
A re-designed PHARMAC website is aimed at helping people better understand the Government drug-funding agency’s work, says Corporate Manager Peter Alsop. More >>
Herceptin Court judgement reassuring
Thursday, 3 April 2008, 2:37 pm | PHARMAC
Today's High Court judgement on Herceptin gives New Zealanders significant reassurances about PHARMAC's processes and decision making, says PHARMAC’s acting chief executive Matthew Brougham. More >>
PHARMAC Working For Flexibility In Brand Changes
Thursday, 20 December 2007, 5:01 pm | PHARMAC
PHARMAC will keep working to find a practicable mechanism to provide some flexibility in its sole supply tender, says Manager Funding and Procurement Steffan Crausaz. More >>
